Prawo i regulacje · 31/03/2023

ANI Pharmaceuticals, Inc. Seeks Registration as Bulk Manufacturer of Controlled Substances

ANI Pharmaceuticals, Inc. has submitted an application to the U.S. government to become a bulk manufacturer of controlled substances, a designation that would allow the company to produce large quantities of certain medications. The application is part of the company's efforts to expand its pharmaceutical operations.